RS63107B1 - Jedinjenja tiazolidinona i njihova upotreba u lečenju psihijatrijskih ili neuroloških poremećaja i inflamacije, posebno neuroinflamacije - Google Patents
Jedinjenja tiazolidinona i njihova upotreba u lečenju psihijatrijskih ili neuroloških poremećaja i inflamacije, posebno neuroinflamacijeInfo
- Publication number
- RS63107B1 RS63107B1 RS20220349A RSP20220349A RS63107B1 RS 63107 B1 RS63107 B1 RS 63107B1 RS 20220349 A RS20220349 A RS 20220349A RS P20220349 A RSP20220349 A RS P20220349A RS 63107 B1 RS63107 B1 RS 63107B1
- Authority
- RS
- Serbia
- Prior art keywords
- psychiatric
- inflammation
- treatment
- neurological disorders
- thiazolidinone compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14170449 | 2014-05-28 | ||
| EP14171024 | 2014-06-03 | ||
| PCT/EP2015/061915 WO2015181337A1 (en) | 2014-05-28 | 2015-05-28 | Thiazolidinone compounds and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation |
| EP15725042.4A EP3148990B1 (en) | 2014-05-28 | 2015-05-28 | Thiazolidinone compounds and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS63107B1 true RS63107B1 (sr) | 2022-04-29 |
Family
ID=54698145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20220349A RS63107B1 (sr) | 2014-05-28 | 2015-05-28 | Jedinjenja tiazolidinona i njihova upotreba u lečenju psihijatrijskih ili neuroloških poremećaja i inflamacije, posebno neuroinflamacije |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US10155754B2 (sr) |
| EP (2) | EP3148990B1 (sr) |
| JP (1) | JP6671301B2 (sr) |
| CN (1) | CN106660976B (sr) |
| AU (2) | AU2015265865B2 (sr) |
| BR (1) | BR112016027901B1 (sr) |
| CA (1) | CA2950354C (sr) |
| DK (1) | DK3148990T3 (sr) |
| ES (1) | ES2910455T3 (sr) |
| HR (1) | HRP20220490T8 (sr) |
| MX (2) | MX2016015627A (sr) |
| PL (1) | PL3148990T3 (sr) |
| RS (1) | RS63107B1 (sr) |
| RU (1) | RU2734253C2 (sr) |
| WO (1) | WO2015181337A1 (sr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015181336A1 (en) * | 2014-05-28 | 2015-12-03 | Universität Bern | Thiazolidinones as cellular anandamide uptake inhibitors and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2798067A (en) * | 1954-03-29 | 1957-07-02 | Eastman Kodak Co | 2-imino-4-thiazolidones and preparation |
| US2739888A (en) * | 1954-03-29 | 1956-03-27 | Eastman Kodak Co | Photographic elements containing thiazolidine derivatives |
| EP1567112B1 (en) * | 2002-11-22 | 2008-10-15 | Smithkline Beecham Corporation | THIAZOLIDIN-4-ONES FOR INHIBITING hYAK3 PROTEINS |
| AU2004264354A1 (en) * | 2003-08-12 | 2005-02-24 | Amgen Inc. | Arylsulfonamidobenzylic compounds |
| US20050042213A1 (en) | 2003-08-14 | 2005-02-24 | Insight Biopharmaceuticals Ltd. | Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof |
| BRPI0416752B8 (pt) | 2003-11-21 | 2021-05-25 | Actelion Pharmaceuticals Ltd | composição farmacêutica, uso de um ou mais compostos, e, compostos |
| JP5199108B2 (ja) * | 2005-11-14 | 2013-05-15 | ユニヴァーシティー オブ サザン カリフォルニア | インテグリン結合小分子 |
| WO2008100977A2 (en) * | 2007-02-14 | 2008-08-21 | N.V. Organon | Carbamates therapeutic release agents as amidase inhibitors |
| WO2009137133A2 (en) * | 2008-02-14 | 2009-11-12 | University Of Washington | 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection |
| EP2435019B1 (en) | 2009-05-29 | 2015-09-23 | Dr. August Wolff GmbH & Co. KG Arzneimittel | Dodeca-2e,4e-diene amides and their use as medicaments and cosmetics |
| GB201007187D0 (en) | 2010-04-29 | 2010-06-09 | Iti Scotland Ltd | Ubiquitination modulators |
-
2015
- 2015-05-28 EP EP15725042.4A patent/EP3148990B1/en active Active
- 2015-05-28 JP JP2016569730A patent/JP6671301B2/ja active Active
- 2015-05-28 RU RU2016147230A patent/RU2734253C2/ru active
- 2015-05-28 US US15/314,067 patent/US10155754B2/en active Active
- 2015-05-28 MX MX2016015627A patent/MX2016015627A/es unknown
- 2015-05-28 WO PCT/EP2015/061915 patent/WO2015181337A1/en active Application Filing
- 2015-05-28 CN CN201580040087.8A patent/CN106660976B/zh active Active
- 2015-05-28 DK DK15725042.4T patent/DK3148990T3/da active
- 2015-05-28 AU AU2015265865A patent/AU2015265865B2/en active Active
- 2015-05-28 CA CA2950354A patent/CA2950354C/en active Active
- 2015-05-28 HR HRP20220490TT patent/HRP20220490T8/hr unknown
- 2015-05-28 PL PL15725042T patent/PL3148990T3/pl unknown
- 2015-05-28 ES ES15725042T patent/ES2910455T3/es active Active
- 2015-05-28 EP EP22152116.4A patent/EP4011879A1/en active Pending
- 2015-05-28 BR BR112016027901-8A patent/BR112016027901B1/pt active IP Right Grant
- 2015-05-28 RS RS20220349A patent/RS63107B1/sr unknown
-
2016
- 2016-11-28 MX MX2020013537A patent/MX2020013537A/es unknown
-
2018
- 2018-12-17 US US16/221,634 patent/US10392377B2/en active Active
-
2019
- 2019-08-21 US US16/546,328 patent/US10774077B2/en active Active
-
2020
- 2020-08-06 AU AU2020213369A patent/AU2020213369B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2950354C (en) | 2023-10-03 |
| US20190382397A1 (en) | 2019-12-19 |
| BR112016027901A2 (pt) | 2017-08-22 |
| AU2020213369A1 (en) | 2020-08-27 |
| WO2015181337A1 (en) | 2015-12-03 |
| EP3148990B1 (en) | 2022-01-19 |
| AU2015265865A1 (en) | 2016-12-15 |
| RU2734253C2 (ru) | 2020-10-13 |
| JP2017516795A (ja) | 2017-06-22 |
| MX2016015627A (es) | 2017-05-04 |
| US20190119265A1 (en) | 2019-04-25 |
| CN106660976A (zh) | 2017-05-10 |
| US10774077B2 (en) | 2020-09-15 |
| EP3148990A1 (en) | 2017-04-05 |
| US10392377B2 (en) | 2019-08-27 |
| HRP20220490T1 (hr) | 2022-05-27 |
| CA2950354A1 (en) | 2015-12-03 |
| RU2016147230A3 (sr) | 2018-12-25 |
| CN106660976B (zh) | 2019-11-26 |
| AU2015265865B2 (en) | 2020-05-07 |
| US20170197952A1 (en) | 2017-07-13 |
| BR112016027901B1 (pt) | 2023-12-12 |
| US10155754B2 (en) | 2018-12-18 |
| MX2020013537A (es) | 2021-02-26 |
| HRP20220490T8 (hr) | 2022-06-10 |
| AU2020213369B2 (en) | 2022-09-22 |
| PL3148990T3 (pl) | 2022-05-30 |
| DK3148990T3 (da) | 2022-04-11 |
| ES2910455T3 (es) | 2022-05-12 |
| EP4011879A1 (en) | 2022-06-15 |
| RU2016147230A (ru) | 2018-07-02 |
| JP6671301B2 (ja) | 2020-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279752B (en) | Polycyclic compounds and their use in the treatment of immune disorders | |
| IL289650A (en) | Azolopyrimidine for the treatment of cancer-related disorders | |
| HRP20210518T1 (hr) | Derivati 2,4-tiazolidindiona, namijenjeni liječenju poremećaja središnjeg živčanog sustava | |
| IL247841A0 (en) | Heterocyclic compounds for use in the treatment of disorders mediated by pi3k gamma | |
| GB2542155B (en) | Use of cannabidiol in the treatment of mental disorders | |
| PT3160464T (pt) | 6-hidroxibuspirona para uso no tratamento de transtornos do movimento | |
| IL246855A0 (en) | Materials for use in the treatment of retinitis | |
| IL275349A (en) | Use of hM4Di in the treatment of seizure disorders | |
| EP3371154A4 (en) | HETEROCYCLIC DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CNS DISORDERS | |
| IL274838A (en) | Use of MIR101 or MIR128 in the treatment of seizure disorders | |
| PL3148990T3 (pl) | Związki tiazolidynonu i ich zastosowanie w leczeniu zaburzeń psychiatrycznych neurologicznych i stanów zapalnych, w szczególności stanów zapalnych układu nerwowego | |
| ZA201806894B (en) | (+)-azasetron for use in the treatment of ear disorders | |
| PT3148990T (pt) | Compostos de tiazolidinona e seu uso no tratamento de condições psiquiátricas ou distúrbios neurológicos e inflamação, particularmente neuroinflamação | |
| PT3442537T (pt) | (+)-azasetrom para utilização no tratamento de doenças do ouvido | |
| GB201603510D0 (en) | Compositions for use in the treatment of neurological disease |